Grace received her BA in Human Evolutionary Biology from Harvard College in 2009. She worked on research and patient education programs as a program director at the Bladder Cancer Advocacy Network before going on to receive her MPH in Behavioral Sciences and Health Education from Emory's Rollins School of Public Health in 2014.
Grace joined the National Cancer Institute as a Presidential Management Fellow in 2014 and completed rotational assignments in NCI's Division of Cancer Treatment and Diagnosis, Division of Cancer Prevention, and Coordinating Center for Clinical Trials, as well as an external detail in the FDA's Office of Hematology and Oncology Products in the Center for Drug Evaluation and Research. She converted into a position in NCI's Cancer Therapy Evaluation Program in 2016.
Grace's research interests include disparities in healthcare access and clinical research participation.
Mishkin G, Minasian LM, Kohn EC, Noone AM, Temkin SM. The generalizability of NCI-sponsored clinical trials accrual among women with gynecologic malignancies. Gynecologic Oncology. 2016;143(3):611-616.
Massett HA, Mishkin G, Rubinstein L, et al. Challenges Facing Early Phase Trials Sponsored by the National Cancer Institute: An Analysis of Corrective Action Plans to Improve Accrual. Clinical Cancer Research. 2016;22(22):5408-5416.